1. Home
  2. NREF vs CRBP Comparison

NREF vs CRBP Comparison

Compare NREF & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Real Estate Finance Inc.

NREF

NexPoint Real Estate Finance Inc.

HOLD

Current Price

$14.80

Market Cap

233.4M

Sector

Real Estate

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$10.67

Market Cap

202.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NREF
CRBP
Founded
2019
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.4M
202.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
NREF
CRBP
Price
$14.80
$10.67
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
$14.75
$48.38
AVG Volume (30 Days)
56.6K
345.6K
Earning Date
10-30-2025
11-12-2025
Dividend Yield
13.52%
N/A
EPS Growth
132.43
N/A
EPS
3.08
N/A
Revenue
$151,560,000.00
N/A
Revenue This Year
$27.88
N/A
Revenue Next Year
$5.41
$220.00
P/E Ratio
$4.81
N/A
Revenue Growth
107.15
N/A
52 Week Low
$12.14
$4.64
52 Week High
$18.09
$20.56

Technical Indicators

Market Signals
Indicator
NREF
CRBP
Relative Strength Index (RSI) 68.52 38.89
Support Level $14.22 $10.05
Resistance Level $14.57 $11.98
Average True Range (ATR) 0.31 0.74
MACD 0.10 0.01
Stochastic Oscillator 96.18 27.33

Price Performance

Historical Comparison
NREF
CRBP

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: